Integral Diagnostics Limited
Research Integral Diagnostics Limited (IDX.AX) on Bullrun: market cap AUD 788.50M, P/E 35.2, dividend yield 4.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIDX.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyAUD
- Market capAUD 788.50M
- P/E35.2
- Dividend yield4.4%
- Financial periodFY2026
- RevenueAUD 788.62M
- Revenue growth25.7%
- Net incomeAUD 21.93M
- Free cash flowAUD 45.60M
- Gross margin95.4%
Valuation Snapshot
latest market cap is AUD 788.50M; P/E is 35.2; dividend yield is 4.4%.
Peer valuation comparison
Latest P/E is 35.17x versus a Healthcare sector median of 24.73x (42.2% above).
Latest dividend yield is 4.41% versus a Healthcare sector median of 1.81% (143.6% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | AUD 788.62M | AUD 21.93M | AUD 45.60M | 95.4% | 0.06 | AUD 51.29M | AUD 597.10M | AUD 675.97M |
| FY2025 | AUD 627.22M | AUD 4.67M | AUD 14.01M | 95.5% | 0.02 | AUD 52.10M | AUD 585.01M | AUD 693.00M |
| FY2024 | AUD 469.70M | -AUD 60.70M | AUD 42.28M | 95.1% | -0.26 | AUD 42.44M | AUD 357.80M | AUD 301.71M |
| FY2023 | AUD 440.10M | AUD 25.04M | AUD 27.42M | 95.2% | 0.11 | AUD 33.86M | AUD 365.08M | AUD 373.05M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 788.50M | 35.2 | 4.4% | 0.09 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.09 AUD, yield 4.4%.
| Year | Dividends/share |
|---|---|
| FY2026 | 0.09 AUD |
| FY2025 | 0.07 AUD |
| FY2024 | 0.06 AUD |
| FY2023 | 0.06 AUD |
| FY2022 | 0.07 AUD |
About Integral Diagnostics Limited
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, allied health professionals, and patients in Australia and New Zealand. It offers medical diagnostic imaging services, such as magnetic resonance imaging, computed tomography, mammography, ultrasound, and radiography, as well as nuclear medicine, including positron emission tomography. The company was founded in 1967 and is headquartered in East Melbourne, Australia.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Integral Diagnostics Limited's market cap?
Integral Diagnostics Limited's market capitalization is AUD 788.50M.
What is Integral Diagnostics Limited's P/E ratio?
Integral Diagnostics Limited's price-to-earnings (P/E) ratio is 35.2.
Does Integral Diagnostics Limited pay a dividend?
Integral Diagnostics Limited has a dividend yield of 4.4%.
What does Integral Diagnostics Limited do?
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, allied health professionals, and patients in Australia and New Zealand. It offers medical diagnostic imaging services, such as magnetic resonance imaging, computed tomography, mammography, ultrasound, and radiography, as well as nuclear medicine, including positron emission tomography. The company was founded in 1967 and is headquartered in East Melbourne, Australia.